Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (75)

2024

  1. Biocompatibility Testing of UV-Curable Polydimethylsiloxane for Human Umbilical Vein Endothelial Cell Culture on-a-Chip

    ACS Omega, Vol. 9, Núm. 28, pp. 30281-30293

  2. Estimated Technological Obsolescence of Computed Tomography Equipment

    Academic Radiology, Vol. 31, Núm. 3, pp. 951-955

  3. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis

    Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7

  4. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction – a randomized trial: The NICE study

    European Journal of Heart Failure, Vol. 26, Núm. 4, pp. 776-784

  5. Population-based disease-group analysis of Spanish excess mortality in the early COVID-19 pandemic period

    Open Heart, Vol. 11, Núm. 1

  6. Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 634-644

2023

  1. Cost Analysis of Magnetic Resonance Imaging and Computed Tomography in Cardiology: A Case Study of a University Hospital Complex in the Euro Region

    Healthcare (Switzerland), Vol. 11, Núm. 14

2022

  1. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273

  2. Cardiac amyloidosis: Description of a series of 143 cases

    Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213

  3. Cost-Effectiveness of a New Outpatient Pulmonology Care Model Based on Physician-to-Physician Electronic Consultation

    Canadian Respiratory Journal, Vol. 2022

  4. Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis

    Archivos de Bronconeumologia, Vol. 58, Núm. 6, pp. 474-481

  5. Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes

    Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428

2021

  1. A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

    Frontiers in Physiology, Vol. 12

  2. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation

    PLoS ONE, Vol. 16, Núm. 6 June

  3. Clinical management in cardiology. Measurement as a means to improvement

    Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 8-14

  4. Clinical management indicators for the cardiovascular area. A note for the debate. Response

    Revista Espanola de Cardiologia

  5. Cost and potential savings of electronic consultation and its relationship with reduction in atmospheric pollution

    Sustainability (Switzerland), Vol. 13, Núm. 22

  6. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 175-182

  7. Noninferiority of heart failure nurse titration versus heart failure cardiologist titration. ETIFIC multicenter randomized trial

    Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 533-543

  8. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1741-1753